Baker Bros. Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Baker Bros. Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-249,123	Closed	-$82.2K	–	111
2023 Q1	$82.2K	Hold	249,123	–	–	﹤0.01%	105
2022 Q4	$179K	Hold	249,123	–	–	﹤0.01%	111
2022 Q3	$299K	Hold	249,123	–	–	﹤0.01%	113
2022 Q2	$296K	Hold	249,123	–	–	﹤0.01%	113
2022 Q1	$538K	Hold	249,123	–	–	﹤0.01%	114
2021 Q4	$371K	Hold	249,123	–	–	﹤0.01%	121
2021 Q3	$727K	Hold	249,123	–	–	﹤0.01%	121
2021 Q2	$822K	Hold	249,123	–	–	﹤0.01%	117
2021 Q1	$937K	Hold	249,123	–	–	﹤0.01%	119
2020 Q4	$879K	Hold	249,123	–	–	﹤0.01%	120
2020 Q3	$1.64M	Hold	249,123	–	–	0.01%	105
2020 Q2	$1.85M	Hold	249,123	–	–	0.01%	105
2020 Q1	$1.17M	Sell	249,123 -18,659	-7%	-$200K	0.01%	99
2019 Q4	$3.45M	Hold	267,782	–	–	0.02%	78
2019 Q3	$2.81M	Hold	267,782	–	–	0.02%	81
2019 Q2	$4.55M	Hold	267,782	–	–	0.03%	65
2019 Q1	$9.02M	Hold	267,782	–	–	0.06%	50
2018 Q4	$7.82M	Hold	267,782	–	–	0.06%	50
2018 Q3	$16.5M	Sell	267,782 -141,563	-35%	-$9.58M	0.11%	45
2018 Q2	$30.2M	Sell	409,345 -5,813	-1%	-$453K	0.23%	34
2018 Q1	$27.2M	Sell	415,158 -88,073	-18%	-$6.65M	0.23%	35
2017 Q4	$42.3M	Hold	503,231	–	–	0.37%	27
2017 Q3	$58.1M	Hold	503,231	–	–	0.47%	19
2017 Q2	$58.8M	Hold	503,231	–	–	0.51%	16
2017 Q1	$62.1M	Buy	503,231 +16,666	+3%	+$2.18M	0.51%	18
2016 Q4	$66.3M	Hold	486,565	–	–	0.65%	16
2016 Q3	$96.8M	Hold	486,565	–	–	0.88%	13
2016 Q2	$63.1M	Hold	486,565	–	–	0.66%	17
2016 Q1	$45.5M	Hold	486,565	–	–	0.48%	25
2015 Q4	$98.6M	Buy	486,565 +67,506	+16%	+$12.1M	0.82%	18
2015 Q3	$60.9M	Hold	419,059	–	–	0.56%	21
2015 Q2	$89.1M	Hold	419,059	–	–	0.78%	17
2015 Q1	$97.1M	Sell	419,059 -9,314	-2%	-$2.25M	0.81%	17
2014 Q4	$98.7M	Buy	+428,373	New	+$91.9M	1.01%	16

Other funds holding BLCM

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

PGAM

Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return

Baker Bros. Advisors's BLCM Position: Q2 2023 in Review

Baker Bros. Advisors sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2023, closing a stake of 249,123 shares — an estimated $82.2K sold.

Baker Bros. Advisors first reported a position in BLCM in Q4 2014 and held it in 34 quarters. The position peaked at $98.7M in Q4 2014. 4 funds tracked by Wall St. Rank hold BLCM as of Q2 2023.

Baker Bros. Advisors reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Baker Bros. Advisors sold 249,123 Bellicum Pharmaceuticals, Inc. shares in Q2 2023, an estimated $82.2K.
Baker Bros. Advisors first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 34 quarters.
Baker Bros. Advisors's Bellicum Pharmaceuticals, Inc. position peaked at $98.7M in Q4 2014.
4 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2023.

Based on Baker Bros. Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.